- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/31 - Chimeric antigen receptors [CAR]
Patent holdings for IPC class A61K 40/31
Total number of patents in this class: 950
10-year publication summary
|
0
|
0
|
1
|
2
|
12
|
38
|
40
|
16
|
15
|
466
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4337 |
36 |
| The Regents of the University of California | 20059 |
21 |
| Board of Regents, The University of Texas System | 5849 |
21 |
| Janssen Biotech, Inc. | 1556 |
20 |
| Kite Pharma, Inc. | 419 |
19 |
| Memorial Sloan-Kettering Cancer Center | 1945 |
17 |
| Allogene Therapeutics, Inc. | 152 |
16 |
| City of Hope | 996 |
15 |
| Juno Therapeutics, Inc. | 417 |
14 |
| Novartis AG | 10730 |
13 |
| The Board of Trustees of the Leland Stanford Junior University | 6451 |
12 |
| The General Hospital Corporation | 4759 |
11 |
| Sloan-Kettering Institute for Cancer Research | 527 |
11 |
| Memorial Hospital for Cancer and Allied Diseases | 301 |
11 |
| Autolus Limited | 255 |
10 |
| CRISPR Therapeutics AG | 368 |
10 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2886 |
10 |
| Dana-Farber Cancer Institute, Inc. | 2585 |
9 |
| Regeneron Pharmaceuticals, Inc. | 4323 |
9 |
| FATE Therapeutics, Inc. | 208 |
8 |
| Other owners | 657 |